Identification of bacteria-derived HLA-bound peptides in melanoma.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2021
Historique:
received: 04 11 2019
accepted: 17 02 2021
pubmed: 19 3 2021
medline: 7 5 2021
entrez: 18 3 2021
Statut: ppublish

Résumé

A variety of species of bacteria are known to colonize human tumours

Identifiants

pubmed: 33731925
doi: 10.1038/s41586-021-03368-8
pii: 10.1038/s41586-021-03368-8
pmc: PMC9717498
mid: NIHMS1742400
doi:

Substances chimiques

Antigens, Bacterial 0
HLA Antigens 0
Peptides 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-143

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : Medical Research Council
ID : MR/V000292/1
Pays : United Kingdom
Organisme : European Research Council
Pays : International
Organisme : NIAID NIH HHS
ID : K01 AI143881
Pays : United States
Organisme : Intramural NIH HHS
Pays : United States
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Références

NPJ Vaccines. 2020 Jan 3;5(1):2
pubmed: 31908851
Cell. 2019 Aug 8;178(4):795-806.e12
pubmed: 31398337
Nat Commun. 2020 Jun 26;11(1):3259
pubmed: 32591509
Genome Res. 2012 Feb;22(2):299-306
pubmed: 22009989
J Clin Invest. 2018 Apr 2;128(4):1563-1568
pubmed: 29360643
Nat Med. 2015 Sep;21(9):1091-100
pubmed: 26280120
Nat Commun. 2016 Jan 29;7:10582
pubmed: 26822383
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Nature. 2019 Oct;574(7780):696-701
pubmed: 31645760
Cancer Res. 2006 Jun 15;66(12):6405-11
pubmed: 16778219
Cell. 2017 Jan 26;168(3):487-502.e15
pubmed: 28111070
J Immunol. 2001 Jul 1;167(1):98-106
pubmed: 11418637
Cancer Discov. 2018 Apr;8(4):403-416
pubmed: 29567829
N Engl J Med. 2014 Dec 4;371(23):2189-2199
pubmed: 25409260
Cancer Res. 1982 Apr;42(4):1530-6
pubmed: 6949641
Folia Microbiol (Praha). 2019 May;64(3):435-442
pubmed: 30554379
NPJ Biofilms Microbiomes. 2017 Nov 29;3:34
pubmed: 29214046
Gastroenterology. 2017 Mar;152(4):851-866.e24
pubmed: 27876571
BMC Cancer. 2015 Aug 08;15:577
pubmed: 26253167
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Int J Cancer. 1997 May 16;71(4):630-7
pubmed: 9178819
Methods Enzymol. 1994;236:405-20
pubmed: 7968625
Sci Rep. 2016 Aug 03;6:30751
pubmed: 27485780
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Science. 2017 Dec 15;358(6369):1443-1448
pubmed: 29170280
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
N Engl J Med. 1998 Aug 20;339(8):520-32
pubmed: 9709046
Nature. 1993 Jan 28;361(6410):359-62
pubmed: 7678924
Science. 2020 May 29;368(6494):973-980
pubmed: 32467386
Apoptosis. 2001 Dec;6(6):431-9
pubmed: 11595832
J Exp Med. 1998 May 18;187(10):1633-40
pubmed: 9584141
Science. 2018 Jan 5;359(6371):104-108
pubmed: 29302014
Cell. 2019 Feb 21;176(5):998-1013.e16
pubmed: 30712876
Sci Transl Med. 2017 Feb 8;9(376):
pubmed: 28179508
Cancer Res. 1984 Sep;44(9):3930-5
pubmed: 6204749
Cell Host Microbe. 2013 Aug 14;14(2):207-15
pubmed: 23954159
Nature. 2015 Apr 30;520(7549):692-6
pubmed: 25901682
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Br J Cancer. 2003 Feb 10;88(3):424-31
pubmed: 12569387
FEMS Immunol Med Microbiol. 2000 Sep;29(1):39-45
pubmed: 10967259
Clin Cancer Res. 2019 Apr 15;25(8):2392-2402
pubmed: 30463850
Oncotarget. 2016 Jun 7;7(23):35169-80
pubmed: 27145267
Science. 1995 Jan 13;267(5195):243-6
pubmed: 7809629
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1754-62
pubmed: 25831525
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
Trends Cancer. 2017 Oct;3(10):726-741
pubmed: 28958390
Science. 2017 Sep 15;357(6356):1156-1160
pubmed: 28912244
Immunity. 2015 Feb 17;42(2):344-355
pubmed: 25680274

Auteurs

Shelly Kalaora (S)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Adi Nagler (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Deborah Nejman (D)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Michal Alon (M)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Chaya Barbolin (C)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Eilon Barnea (E)

Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.

Steven L C Ketelaars (SLC)

Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Kuoyuan Cheng (K)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Kevin Vervier (K)

Wellcome Sanger Institute, Cambridge, UK.

Noam Shental (N)

Department of Mathematics and Computer Science, Open University of Israel, Raanana, Israel.

Yuval Bussi (Y)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Ron Rotkopf (R)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Ronen Levy (R)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Gil Benedek (G)

Tissue Typing and Immunogenetics Unit, Hadassah Medical Center, Jerusalem, Israel.

Sophie Trabish (S)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Tali Dadosh (T)

Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.

Smadar Levin-Zaidman (S)

Department of Chemical Research Support, Weizmann Institute of Science, Rehovot, Israel.

Leore T Geller (LT)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Kun Wang (K)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Polina Greenberg (P)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Gal Yagel (G)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Aviyah Peri (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Garold Fuks (G)

Department of Physics of Complex Systems, Weizmann Institute of Science, Rehovot, Israel.

Neerupma Bhardwaj (N)

The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

Alexandre Reuben (A)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Leandro Hermida (L)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Sarah B Johnson (SB)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jessica R Galloway-Peña (JR)

Department of Veterinary Pathobiology, Texas A&M University, Houston, TX, USA.

William C Shropshire (WC)

Department of Infectious Diseases, MD Anderson Cancer Center, Houston, TX, USA.

Chantale Bernatchez (C)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cara Haymaker (C)

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Reetakshi Arora (R)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Lior Roitman (L)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Raya Eilam (R)

Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.

Adina Weinberger (A)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Maya Lotan-Pompan (M)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Michal Lotem (M)

Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Arie Admon (A)

Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel.

Yishai Levin (Y)

The de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel.

Trevor D Lawley (TD)

Wellcome Sanger Institute, Cambridge, UK.

David J Adams (DJ)

Wellcome Sanger Institute, Cambridge, UK.

Mitchell P Levesque (MP)

Faculty of Medicine, University of Zurich Hospital, University of Zurich, Zurich, Switzerland.

Michal J Besser (MJ)

The Ella Lemelbaum Institute for Immuno Oncology and Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Jacob Schachter (J)

The Ella Lemelbaum Institute for Immuno Oncology and Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Ofra Golani (O)

Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.

Eran Segal (E)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Naama Geva-Zatorsky (N)

The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
MaRS Centre, Canadian Institute for Advanced Research (CIFAR) Azrieli Global Scholar, Toronto, Ontario, Canada.

Eytan Ruppin (E)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Pia Kvistborg (P)

Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Scott N Peterson (SN)

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Jennifer A Wargo (JA)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Ravid Straussman (R)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Yardena Samuels (Y)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. yardena.samuels@weizmann.ac.il.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH